ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 87 filers reported holding ANTARES PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $484,000 | -26.1% | 556,754 | +2.8% | 0.00% | 0.0% |
| Q4 2015 | $655,000 | -28.6% | 541,421 | +0.3% | 0.00% | 0.0% |
| Q3 2015 | $917,000 | -19.9% | 539,672 | -1.9% | 0.00% | 0.0% |
| Q2 2015 | $1,145,000 | +23.9% | 550,256 | +61.4% | 0.00% | 0.0% |
| Q1 2015 | $924,000 | +5.8% | 340,842 | +0.4% | 0.00% | 0.0% |
| Q4 2014 | $873,000 | +38.8% | 339,535 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $629,000 | -30.1% | 343,624 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $900,000 | -17.7% | 336,901 | +7.9% | 0.00% | -50.0% |
| Q1 2014 | $1,093,000 | -20.9% | 312,236 | +1.0% | 0.00% | 0.0% |
| Q4 2013 | $1,382,000 | +6.6% | 309,207 | -3.2% | 0.00% | 0.0% |
| Q3 2013 | $1,296,000 | +4.2% | 319,332 | +6.8% | 0.00% | 0.0% |
| Q2 2013 | $1,244,000 | – | 299,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |